secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2022-07-01T23:59:59+00:00
Accession:  0001104659-22-076551
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA shareholders approve doubling authorized shares to 200M and reverse split range
--------------------------------------------------------------------------------

- Authorized common shares increased from 100M to 200M via Certificate of Amendment.
- Shareholders authorized reverse stock split in range of 1-for-2 to 1-for-10, if board elects.
- Class III directors Julie O'Neill and Reinhard Kandera elected for three-year terms.
- Stockholders ratified PwC Wirtschaftsprüfung GmbH as auditor for FY 2022.
- 2019 Stock Incentive Plan amended to increase authorized shares by 1M shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465922076551/0001104659-22-076551-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465922076551/tm2220184d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-076551

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer